BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18367832)

  • 1. Assessment of treatment practice patterns for severe hemophilia A: a global nurse perspective.
    Khair K; Lawrence K; Butler R; O'Shea E; Christie BA
    Acta Haematol; 2008; 119(2):115-23. PubMed ID: 18367832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.
    Castaman G; Rocino A; Mazzucconi MG; Zanon E; Gagliano F; Molinari AC
    Blood Transfus; 2015 Oct; 13(4):631-8. PubMed ID: 26057481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized prophylaxis in people with hemophilia A: challenges and achievements.
    Ar MC; Baslar Z; Soysal T
    Expert Rev Hematol; 2016 Dec; 9(12):1203-1208. PubMed ID: 27809624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis.
    Ross C; Goldenberg NA; Hund D; Manco-Johnson MJ
    Pediatrics; 2009 Nov; 124(5):1267-72. PubMed ID: 19822585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice patterns in haemophilia A therapy -- global progress towards optimal care.
    Geraghty S; Dunkley T; Harrington C; Lindvall K; Maahs J; Sek J
    Haemophilia; 2006 Jan; 12(1):75-81. PubMed ID: 16409179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous access devices in patients with hemophilia.
    Valentino LA; Kapoor M
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns in haemophilia A therapy--a survey of treatment centres in the United States.
    Butler RB; McClure W; Wulff K
    Haemophilia; 2003 Sep; 9(5):549-54. PubMed ID: 14511293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an International Prophylaxis Study Group global survey.
    Ignas DM; Doria AS; von Drygalski A; Blanchette VS; Chang EY; Dover S; Fischer K; Gibikote S; Keshava SN; Querol F; Abad A; Babyn P
    Haemophilia; 2020 Jul; 26(4):685-693. PubMed ID: 32441402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States.
    Thornburg CD; Carpenter S; Zappa S; Munn J; Leissinger C
    Haemophilia; 2012 Jul; 18(4):568-74. PubMed ID: 22335526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.
    Walsh CE; Valentino LA
    Haemophilia; 2009 Sep; 15(5):1014-21. PubMed ID: 19493018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.
    Ragni MV; Fogarty PJ; Josephson NC; Neff AT; Raffini LJ; Kessler CM
    Haemophilia; 2012 Jan; 18(1):63-8. PubMed ID: 21539695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
    Khawaji M; Astermark J; Berntorp E
    Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.
    Duncan N; Shapiro A; Ye X; Epstein J; Luo MP
    Haemophilia; 2012 Sep; 18(5):760-5. PubMed ID: 22548353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies.
    Carcao M; Chambost H; Ljung R
    Haemophilia; 2010 Mar; 16 Suppl 2():4-9. PubMed ID: 20132332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing education tailored to clinical roles: genetics education for haemophilia nurses.
    Burke S; Barker C; Marshall D
    Nurse Educ Today; 2012 Jan; 32(1):52-6. PubMed ID: 21356571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges.
    Coppola A; Tagliaferri A; Di Capua M; Franchini M
    Semin Thromb Hemost; 2012 Feb; 38(1):79-94. PubMed ID: 22314606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis for severe hemophilia: experience from Europe and the United States.
    van den Berg HM; Fischer K
    Semin Thromb Hemost; 2003 Feb; 29(1):49-54. PubMed ID: 12640565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.
    Valentino LA
    Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.